WO2016055737A1
|
|
Deglycation activity of a combination of an extract of salvia miltiorrhiza and of niacin and/or niacinamide
|
JP2015147798A
|
|
Stimulation of synthesis and of activity of isoform of loxl (lysyl oxidase-like) for stimulating formation of elastic fiber
|
KR20150029669A
|
|
Use of substances to protect fgf-2 or fgf-beta growth factor
|
WO2015067525A1
|
|
Oligopeptides and uses of same
|
EP3043873A1
|
|
Cosmetic or dermatological use of an extract of tapirira guianensis
|
CN104736136A
|
|
Cosmetic or pharmaceutical moisturising ingredient
|
FR3003758A1
|
|
COSMETIC OR DERMATOLOGICAL USE OF A POLYGONUM BISTORTA EXTRACT
|
FR3000488A1
|
|
NOVEL DERIVATIVES OF SINAPIC ACID AND THEIR COSMETIC OR PHARMACEUTICAL USES
|
FR2999926A1
|
|
USES OF A DNA METHYLATION INHIBITORY SUBSTANCE FOR STIMULATING THE FORMATION OF ELASTIC FIBERS
|
FR2997406A1
|
|
HYALURONATE AND GLUCOMANNAN POLYMER
|
FR2976587A1
|
|
In vitro dosing method by immunological technique
|
FR2954702A1
|
|
Agent stimulating the expression of loxl
|
JP2010059196A
|
|
Synthesis of loxl (lysyl oxidase-like) isoform for stimulating formation of elastic fiber, and stimulation of activity
|
KR20160028495A
|
|
Slimming composition
|
KR20100040737A
|
|
Slimming composition
|
FR2928548A1
|
|
SUBSTANCES INCREASING THRESHOLD OF ACTIVATION OF IMMUNE CELLS
|
FR2927632A1
|
|
Cornea and muqueuse reconstructed.
|